Delivery Order SPE2DB24D1007-SPE2DB25FBZFU
Award Date
11/12/24
Potential Completion Date
11/13/24
Potential Value
$4.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,855.89 firm fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of September 19, 2024 and was awarded on September 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,549.17 firm fixed-price delivery order is for the supply of dapagliflozin 10 mg tablets, a medication used to treat diabetes. The contract has an ultimate completion date of July 3, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, valued at $5,437.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,117,414 units of Dapagliflozin 10 mg tablets, a medication used to treat diabetes. The contract is not set aside and is a firm fixed-price agreement with a performance period ending on May 5, 2025. Amerisourcebergen Drug Corp holds a...
This federal contract award, valued at $5,356.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dapagliflozin 10 mg tablets, a medication used to treat type 2 diabetes, with a completion date of July 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, with ID SPE2DB24D3013|SPE2DB25FFKXS, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,443.60 firm-fixed-price delivery order is for the supply of 4,567,926,303 tablets of the diabetes medication Dapagliflozin 10 mg. The contract has an ultimate completion date of April 16, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,884.08 firm fixed-price delivery order is for the supply of 4566448537 DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. The contract has an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $50,533.78 firm fixed-price delivery order is for the supply of Dapagliflozin 10 mg tablets, a medication used to manage diabetes. The contract has an ultimate completion date of July 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award, valued at $4,300.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used in diabetes management. The contract has an ultimate completion date of November 15, 2024 and is a Firm Fixed Price agreement. This award is not associated with a set-aside designation, indicating...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Dapagliflozin 10 mg tablets, a medication used to treat diabetes. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,376.58 and a completion date of March 19, 2025. The contract was awarded on March 18, 2025 and does not have a set-aside designation, indicating...
This is a $8,678.74 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the provision of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat diabetes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive...